The application and inflammation effects of hypertonic saline hydroxyethyl starch 40 and mannitol injection in elder patients during intracranial tumour neurosugery

The application of hypertonic saline hydroxyethyl starch 40 and mannitol injection in elder patients during intracranial tumour neurosugery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16009005

Enrollment

Unknown

Registered

2016-08-10

Start date

2016-08-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intracranial tumour

Interventions

mannitol :mannitol

HSH40:HSH40

HSH40+ mannitol :HSH40+ mannitol

Eligibility

Sex/Gender

All

Age

60 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) ASA II-III aged>60 year; (2) Intracranial tumour neurosugery Control intracranial pressure; (3) Agree to attend this study.

Exclusion criteria

Exclusion criteria: (1) Acute Cardiac and cerebral ischemia, cardiac insufficiency, renal insufficiency; (2) Other serious systemic diseases; (3) Emergency craniocerebral surgery; (4) Disagree with this study.

Design outcomes

Primary

Measure	Time frame
Blood pressure;heart ratio;blood gas analysis;CVP;urine volume;WBC;IL-1;IL-1;S100;	—

Countries

China

Contacts

Public ContactJiabao Hou

Remin Hospital of Wuhan University

boh57@126.com+86 13407195618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026